Navigation Links
SPC2996 in Medical Technology

Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research

Bcl-2 Antagonist shown to be therapeutically effective in a mouse model of Chronic Lymphocytic Leukaemia COPENHAGEN, 18 April 2007 - Santaris Pharma, the Danish biopharmaceutical company developing RNAi drugs, yesterday presented encouraging data at the American Association for Cancer Research A...

Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia

First RNA Antagonist Medicine to Be Tested in Patients Reduces Severity of Adult Leukaemia Copenhagen, 6th June 2007 - Santaris Pharma, the Danish biopharmaceutical company, announced today that SPC2996, the Company's new RNA Antagonist of Bcl-2, has shown early evidence of efficacy in an initia...
SPC2996 in Biological Technology

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

... own development activities within metabolic disorders and infectious diseases, it has been decided to divest the activities within the development of spc2996 targeting CLL. This process is ongoing. EZN3042-Survivin In February 2009 Santaris Pharma's collaboration partner Enzon Pharmaceuticals ...
SPC2996 in other areas

News - FDA Approves IND for SPC2996 in Chronic Lymphocytic Leukaemia

SPC2996 is the first of a new class of LNA-based investigational drugs known as ... SPC2996 acts by inhibiting the synthesis of Bcl-2, a key intracellular protein ...

Definition of oligonucleotide SPC2996 - National Cancer Institute Drug ...

The search textbox has an autosuggest feature. ... Oligonucleotide SPC2996 binds to and inactivates Bcl-2 mRNA, thereby inhibiting ...

SPC2996 in Chronic Lymphocytic Leukaemia - Full Text View ...

SPC2996 in Chronic Lymphocytic Leukaemia. This study is ongoing, but not recruiting participants. ... Dose Escalating, Phase I/II Study of SPC2996,an LNA ...

Investigational New Drug Application Approved for SPC2996 for Treatment ...

SPC2996 is an RNA antagonist that has been designed to reduce Bcl-2 protein ... II study is currently ongoing to evaluate SPC2996 in relapsed or refractory CLL. ...

Santaris Pharma presents positive preclinical data on SPC2996 at the ...

SPC2996 was tested for anti-leukaemic activity over two weeks in this model ... Therapy with SPC2996 resulted in a 54% reduction (p=0.043) in the number of CLL ...

Report and Accounts 2005

Investigational New Drug application for SPC2996, which enabled ... These compounds, like SPC2996, have been ... SPC2996, under Good Manufacturing Practice ...
Other Tags
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... April issue of Experimental Biology and Medicine ... Rex Gaskins and Paul Kenis in the Institute ... the University of Illinois Urbana-Champaign describe their recent ... underlie a variety of cell functions including energy ... crucial roles in regulating normal cellular behavior, redox ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
(Date:4/17/2014)... 17, 2014U.S. military personnel who served in Iraq ... traumatic brain injury (TBI) were compared to military ... medical reasons. Differences in measures of overall disability, ... after injury are reported in an article in ... from Mary Ann Liebert, Inc., publishers. The article ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
(Date:4/17/2014)... One day about eight years ago, Katia Silvera , ... her father were on a field trip in a mountainous ... they had never seen before. , Unable to identify it, ... The orchid turned out to be an unnamed species. So ... . , "Lophiaris" is the genus name, comprising about 40 ...
(Date:4/17/2014)... If a restaurant ... he can expect his premises to be trashed. Warnings like ... is enough to make restaurant owners pay up. Similarly, mafia-like ... in other birds, nests. If the host birds throw the ... destroying the entire nest. Consequently, it is beneficial for hosts ...
(Date:4/17/2014)... fragmentation of forests in the Amazon help create ... to rapid and widespread forest loss during drought ... findings show that forests in the Amazon could ... with forest fires lead to large-scale loss of ... assistant professor of geography, Penn State. , "We ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3Drought and fire in the Amazon lead to sharp increases in forest tree mortality 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 3
Other Contents